SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-24-049147
Filing Date
2024-04-26
Accepted
2024-04-26 16:15:24
Documents
22
Period of Report
2024-06-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A atra-20240425.htm   iXBRL DEF 14A 1657887
2 GRAPHIC img121827346_0.jpg GRAPHIC 5500
3 GRAPHIC img121827346_1.jpg GRAPHIC 132642
4 GRAPHIC img121827346_2.jpg GRAPHIC 266354
5 GRAPHIC img121827346_3.jpg GRAPHIC 147729
6 GRAPHIC img121827346_4.jpg GRAPHIC 18463
7 GRAPHIC img121827346_5.jpg GRAPHIC 9105
8 GRAPHIC img121827346_6.jpg GRAPHIC 9438
9 GRAPHIC img121827346_7.jpg GRAPHIC 155819
10 GRAPHIC img121827346_8.jpg GRAPHIC 123158
11 GRAPHIC img121827346_9.jpg GRAPHIC 102155
  Complete submission text file 0000950170-24-049147.txt   4803579

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT atra-20240425.xsd EX-101.SCH 35232
25 EXTRACTED XBRL INSTANCE DOCUMENT atra-20240425_htm.xml XML 208846
Mailing Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320
Business Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320 805-623-4244
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36548 | Film No.: 24883956
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)